Live Rate
Open | |
---|---|
High | |
Low | |
Prev. Close | |
Lower circuit | |
Upper circuit | |
52w High | |
52w Low | |
P/E Ratio |
Studio LSD Listing Price
Exchange | Listing Price | Gain/Loss | % |
---|---|---|---|
NSE | ₹43.20 | -₹10.80 | -20.00% |
Studio LSD Subscription
Last updated on 20-Aug-2025 18:32:02
Category | Offered | Applied | Times |
---|---|---|---|
QIB | 132000 | 132000 | 1 |
HNIs | 5172000 | 6508000 | 1.26 |
bHNI | 3448000 | 3310000 | 0.96 |
sHNI | 1724000 | 3198000 | 1.85 |
Individual | 7758000 | 35568000 | 4.58 |
Total | 13062000 | 42208000 | 3.23 |
Application-Wise Breakup ![]() | |||
---|---|---|---|
Category | Reserved | Applied | Times |
HNIs (10L+) | 575 | 81 | 0.14 |
HNIs (3-10L) | 287 | 447 | 1.56 |
Individual | 1940 | 8892 | 4.58 |
Subscription Demand (in ₹ crore) | |||
---|---|---|---|
Category | Offered | Demand | Times |
QIB | 0.71 | 0.71 | 1 |
FII | - | 0 | - |
FI | - | 0 | - |
IC | - | 0 | - |
MF | - | 0 | - |
OTH | - | 0.71 | - |
HNIs | 27.93 | 35.14 | 1.26 |
bHNI | 18.62 | 17.87 | 0.96 |
sHNI | 9.31 | 17.27 | 1.85 |
Individual | 41.89 | 192.07 | 4.58 |
Total | 70.53 | 227.92 | 3.23 |
QIB Interest Cost Per Share (7 Days) | |||||
---|---|---|---|---|---|
@7% ₹0.1 | @8% ₹0.1 | @9% ₹0.1 | @10% ₹0.1 | @11% ₹0.1 | @12% ₹0.1 |
Studio LSD Lot(s) Distribution
Category | Lot(s) | Qty | Amount | Reserved |
---|---|---|---|---|
bHNI | 10 | 20000 | 1080000 | 575 |
Studio LSD Reservation
Category | Shares Offered | % |
---|---|---|
QIB | 132000 | 0.96% |
HNI | 5172000 | 37.61% |
INDIVIDUAL | 7758000 | 56.42% |
Market Maker | 688000 | 5% |
Total | 13750000 | 100% |
Studio LSD About
IPO Reservation
Investor Category | Shares Offered | No. of Shares |
---|---|---|
Individual | 56.42% | 7758000 |
BHNI | 25.08% | 3448000 |
SHNI | 12.54% | 1724000 |
QIB | 0.96% | 132000 |
Market Maker | 5.00% | 688000 |
Total | 100.00% | 13750000 |
Studio LSD IPO Details
Total Issue Size | 1,37,50,000 shares (aggregating up to ₹70.13 Cr) |
Fresh Issue | 1,10,00,000 shares (aggregating up to ₹56.1 Cr) |
Offer for Sale | 27,50,000 shares of ₹10 (aggregating up to ₹14.03 Cr) |
Issue Type | Bookbuilding IPO |
Listing At | NSE SME |
Share Holding Pre Issue | 4,08,91,755 shares |
Share Holding Post Issue | 5,18,91,755 shares |
Market Maker's Portion | 6,88,000 shares |
Market Maker | Rikhav Securities |
Key Performance Indicator
KPI | Mar-25 | Mar-24 | Mar-23 |
---|---|---|---|
ROE | 53.78% | 104.71% | 78.42% |
ROCE | 57.29% | 92.44% | 74.29% |
RONW | 53.78% | 104.71% | 78.42% |
EPS (basic) | 2.85 | 2.67 | 0.68 |
P/E Pre IPO | 17.87 | ||
P/E Post IPO | 22.68 |
Financial Details In Crores
Period Ended | Mar-25 | Mar-24 | Mar-23 |
---|---|---|---|
Assets | 46.67 | 36.49 | 18.16 |
Total Income | 105.01 | 102.49 | 46.71 |
Profit After Tax | 11.67 | 10.9 | 2.79 |
EBITDA | 15.51 | 14.82 | 3.74 |
Net Worth | 27.54 | 15.87 | 4.96 |
Reserves and Surplus | 19.36 | 15.86 | 4.95 |
Total Borrowing | 0 | 0 | 0.06 |
About Company
Incorporation: February 2017
Business: Multimedia production house specializing in original content for television and OTT platforms.
Focus: Innovative storytelling, high-quality genre-defining shows, and captivating digital series with strong creative vision.
Operations: End-to-end content creation — from concept development to distribution — including project financing, casting, location scouting, set building, budgeting, production, and post-production.
Key Services:
Concept, scriptwriting, and screenplay development
Line production
Post-production services
Distribution & marketing support
Consultation & strategy development
Innovation & adaptation
Team Strength: 16 departmental employees (as of Jan 31, 2025)
Market Presence: Serving television and OTT platforms across India
Strength
Experienced Management & Industry Expertise: A leadership team with deep roots in the entertainment industry.
Comprehensive Production Capabilities: In-house capabilities that cover the end-to-end production process.
Diverse Content Portfolio: A wide range of content across genres and formats, tailored for different platforms and audiences.
Weakness
Looks like clear avoid ,
Customer Concentration Risk: Heavy reliance on a few key customers; loss or reduction of their contracts could significantly impact revenue.
Project Execution Risk: Delays, cost overruns, or failure to complete projects as planned may adversely affect financial performance.
Audience Preference Risk: Changes in viewer tastes and preferences could reduce demand for content and harm business prospects.
Studio LSD Latest Announcements
Date | Subject | Attachment Text |
---|
Studio LSD Financial Results
Studio LSD Lead Manager(s)
Studio LSD Address
Unit No.302,301, 3rd Floor, Laxmi Mall,
Laxmi Industrial Estate New Link Road
Andheri West,
Mumbai, Maharashtra, 400053
Phone: +91 91371 95384
Email: compliance@studiolsd.in
Website: https://www.studiolsd.in/